[
  {
    "ts": null,
    "headline": "Edwards Comments on JenaValve Acquisition",
    "summary": "IRVINE, Calif., January 09, 2026--Edwards Lifesciences (NYSE: EW) today announced that the U.S. District Court for the District of Columbia has granted the motion from the U.S. Federal Trade Commission (FTC) for an injunction blocking the company’s proposed acquisition of JenaValve Technology. As a result, Edwards will not acquire JenaValve.",
    "url": "https://finnhub.io/api/news?id=d87ac57e2aad2f59dbfba048a5363fe84ea3e96e34f28dc7e154d49788f623c5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768002480,
      "headline": "Edwards Comments on JenaValve Acquisition",
      "id": 138052758,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "EW",
      "source": "Yahoo",
      "summary": "IRVINE, Calif., January 09, 2026--Edwards Lifesciences (NYSE: EW) today announced that the U.S. District Court for the District of Columbia has granted the motion from the U.S. Federal Trade Commission (FTC) for an injunction blocking the company’s proposed acquisition of JenaValve Technology. As a result, Edwards will not acquire JenaValve.",
      "url": "https://finnhub.io/api/news?id=d87ac57e2aad2f59dbfba048a5363fe84ea3e96e34f28dc7e154d49788f623c5"
    }
  }
]